Clinical Trial Update: Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Neonates [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates safety and immunogenicity of recombinant hepatitis B vaccines in neonates. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Disease
• Hepatitis B
• Liver Disease

Drugs mentioned

• Recombinant hepatitis B vaccine (hepatitis B vaccine, recombinant)

Snippet

Sponsor: Shenzhen Kangtai Biological Products Co., LTD | Conditions: Hepatitis, Hepatitis B | Phase 4 | Status: UNKNOWN